MiNK Therapeutics, Inc. (INKT)
(Delayed Data from NSDQ)
$0.97 USD
+0.01 (1.04%)
Updated May 31, 2024 04:00 PM ET
After-Market: $0.97 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.10 | 0.00% |
Earnings Summary
For their last quarter, MiNK Therapeutics, Inc. (INKT) reported earnings of -$0.11 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 31.25%. Look out for INKT's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting a year-over-year increase of 44.44%.
Earnings History
Price & Consensus
Zacks News for INKT
MiNK Therapeutics, Inc. (INKT) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
INKT: What are Zacks experts saying now?
Zacks Private Portfolio Services